Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2025-12-25 @ 3:54 AM
NCT ID:
NCT02052102
Eligibility Criteria:
Inclusion Criteria:
* Female patients with pathologically confirmed left sided breast cancer eligible for adjuvant breast/chest wall plus or minus regional nodal radiotherapy
* Women patients with age group between 18 and 70 years old
* Karnofsky performance score ≥ 70
* Ability to hold breath for at least 20 sec (for DIBH cohorts only)
* Life expectancy \>10 years
Exclusion Criteria:
* For patients with prior Anthracycline based chemotherapy or Herceptin, if there is \< 1.0 cm of heart on at least 3 slices ( 3 mm slices) on the FB scan, the patient will be considered a screen failure.
* Previously irradiated or recurrent breast/chest wall tumours or previous malignancy other than non-melanoma skin cancer unless disease free for a minimum of 5 years prior to study entry
* Patients that require a shell for breast immobilization
* Patients requiring a boost
* Stage IV disease
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02052102
Study Brief:
Protocol Section:
NCT02052102